Gender-related dimorphism in aortic insufficiency in murine mucopolysaccharidosis type I

Journal of Heart Valve Disease

Volumn 18, Issue 5, 2009, Pages 524-529

  Tolar, Jakub ^a   Braunlin, Elizabeth ^b   Riddle, Megan ^a   Peacock, Brandon ^a   McElmurry, Ron T ^a   Orchard, Paul J ^a   Blazar, Bruce R ^a  

^a Division of Hematology   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; MACROPHAGE ELASTASE;

ACOUSTIC MICROSCOPY; ANIMAL; AORTA VALVE REGURGITATION; ARTICLE; C57BL MOUSE; DISEASE MODEL; ECHOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HURLER SYNDROME; MALE; MOUSE; PATHOPHYSIOLOGY; SEX DIFFERENCE;

ANIMALS; AORTIC VALVE INSUFFICIENCY; DISEASE MODELS, ANIMAL; FEMALE; MALE; MATRIX METALLOPROTEINASE 12; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICROSCOPY, ACOUSTIC; MUCOPOLYSACCHARIDOSIS I; SEX FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77449089925     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Mak KH, Ma S, Heng D, et al. Impact of sex, metabolic syndrome, and diabetes mellitus on cardiovascular events. Am J Cardiol 2007;100:227-233
2. Kurtulmus N, Bos S, Arslan S, Kurt T, Tukek T, Ince N. Differences in risk factors for acute coronary syndromes between men and women. Acta Cardiol 2007;62:251-255
3. Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 1999;83:897-902
4. Lederle FA, Johnson GR, Wilson SE, et al. Prevalence and association of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann Int Med 1997;126:441-449
5. Cavasin MA, Tao Z, Menon S, Yang XP. Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice. Life Sci 2004;75:2181-2192
6. Woodrum DT, Ford JW, Ailawadi G, et al. Gender differences in rat aortic smooth muscle cell matrix metalloproteinase-9. J Am Coll Sure 2005;201-398-404
7. Clarke LA, Russell CS, Pownall S, et al. Murine mucopolysaccharidosis type I:Targeted disruption of the murine alpha-L-iduronidase gene. Hum Mol Genet 1997;6:503-511
8. Braunlin E, Mackey-Bojack S, Panoskaltsis-Mortari A, et al. Cardiac functional and histopathologic findings in humans and mice with mucopolysaccharidosis type I:Implications for assessment of therapeutic interventions in Hurler syndrome. Pediatr Res 2006;59:27-32
9. Jordan MC, Zheng Y, Ryazantsev S, Rozengurt N, Roos KP, Neufeld EF. Cardiac manifestations in the mouse model of mucopolysaccharidosis I. Mol Genet Metab 2005;86:233-243
10. Di Domenico C, Villani GR, Di Napoli D, et al. Gene therapy for a mucopolysaccharidosis type I murine model with lentiviral-IDUA vector. Hum Gene Ther 2005;16:81-90
11. Liu Y, Xu L, Hennig AK, Kovacs A, et al. Liverdirected neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice. Mol Ther 2005;11:35-47
12. Bach G, Friedman R, Weissmann B, Neufeld EF. The defect in the Hurler and Scheie syndromes:Deficiency of ?-L-iduronidase. Proc Natl Acad Sci USA 1972;69:2048-2051
13. Renteria VG, Ferraris VJ, Roberts WC. The heart in the Hurler syndrome:Gross, histologic and ultrastructural observations in five necropsy cases. Am J Cardiol 1976;38:487-501
14. Brosius FC, HI, Roberts WC. Coronary artery disease in the Hurler syndrome. Qualitative and quantitative analysis of the extent of coronary narrowing at necropsy in six children. Am J Cardiol 1981;47:649-653
15. Dangel JH, Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders-clinical and echocardiography findings in 64 patients. Eur JPediatr 1998;157:534-538
16. Krovetz LJ, Schiebler GL. Cardiovascular manifestations of the genetic mucopolysaccharidoses. Birth Defects 1972;8:192-196
17. Braunlin EA, Stauffer NR, Peters CH, et al. Usefulness of bone marrow transplantation in the Hurler syndrome. Am J Cardiol 2003;92:882-886
18. Vinallonga X, Sanz N, Balaguer A, Miro L, Ortega JJ, Casaldaliga J. Hypertrophic cardiomyopathy in mucopolysaccharidoses:Regression after bone marrow transplantation. Pediatr Cardiol 1992;13:107-109
19. Gatzoulis MA, Vellodi A, Redington AN. Cardiac involvement in mucopolysaccharidoses:Effects of allogeneic bone marrow transplantation. Arch Dis Child 1995;73:259-260
20. Braunlin EA, Rose AG, Hopwood JJ, Candel RD, Krivit W. Coronary artery patency following long term successful engraftment 14 years after bone marrow transplantation in a patient with Hurler syndrome. Am J Cardiol 2001;88:1075-1077
21. Ma X, Tittiger M, Knutsen RH, et al. Upregulation of elastase proteins results in aortic dilatation in mucopolysaccharidosis I mice. Mol Genet Metab 2008;94:298-304
22. Roman MJ, Devereux RB, Niles NW, et al. Aortic root dilation as a cause of isolated, severe aortic regurgitation. Ann Int Med 1987;106:800-807
23. Seder JD, Burke JF, Pauletto FJ. Prevalence of aortic regurgitation by color flow Doppler in relation to aortic root size. J Am Soc Echocardiogr 1990;3:316-319
24. Hinek A, Wilson SE. Impaired elastogenesis in Hurler disease:Dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly. Am J Pathol 2000;156:9259-9238
25. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-1811
26. Grandas OH, Mountain DJ, Kirkpatrick SS, et al. Effect of hormones on matrix metalloproteinases gene regulation in human aortic smooth muscle cells. J Surg Res 2008;148:94-99
27. di Natoli AK, Medley TL, Ahimastos AA, et al. Sex steroids modulate human aortic smooth muscle cell matrix protein deposition and matrix metalloproteinase expression. Hypertension 2005;46:1129-1134
28. Henriques TA, Huang J, D'Souza SS, Daugherty A, Cassis LA. Orchiectomy, but not ovariectomy, regulates angiotensin II-induced vascular disease in apolipoprotein E-deficient mice. Endocrinology 2004;145:3866-3872
29. Beesley CE, Meaney CA, Greenland G, et al. Mutational analysis of 85 mucopolysaccharidosis type I families:Frequency of known mutations, identification of 17 novel mutations and in vitro expression of missense mutations. Hum Genet 2001;109:503-511
30. Pastores GM, Arn P, Beck M, et al. The MPS I registry:Design, methodology, and early findings of a global disease registry for monitoring patients with mucopolysaccharidosis type I. Mol Genet Metab 2007;91:37-47